Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.Journal of Gastroenterology and Hepatology|December 22, 2017
Predicting response after infliximab salvage in acute severe ulcerative colitisMatthew C Choy, Dean Seah, Alexandra Gorelik, et al.Journal of Crohn'S & Colitis|August 18, 2023
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and EndoscopicallyEmily K Wright, Maria Chaparro, Paolo Gionchetti, et al.Inflammatory Bowel Diseases|April 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitisManjeet K Goyal, Priyata Dutta, Matthew C Choy, et al.Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.Alimentary Pharmacology & Therapeutics|February 20, 2021
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonatesEmma Flanagan, Emily K Wright, Winita Hardikar, et al.Journal of Gastroenterology and Hepatology|October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, AustraliaUma Mahadevan, Vipul Jairath, Jakob Begun, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Pageof 11